Concepedia

Evaluation of the Clinical and Economic Impact of a Brand Name—to‐Generic Warfarin Sodium Conversion Program

Daniel M. Witt, Donald J. Tillman, Christy M. Evans, Tatyana V. Plotkin, Melanie A. Sadler

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2003 · 22 citations · 11 references

Abstract

Most of these patients were successfully switched from brand name to generic warfarin. However, supplemental INR monitoring is warranted when one warfarin product is substituted for another to allow timely detection of those patients who experience significant changes in anticoagulation response.

References

11

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

F.R. Rosendaal, Suzanne C. Cannegieter, F.J.M. van der Meer et al. · Thrombosis and Haemostasis · 1993 · 2K citations

Oral Anticoagulant Therapy, Pharmacotherapy, Optimal Achieved Intensity +19

Comparison of an Anticoagulation Clinic With Usual Medical Care

Elaine Chiquette, Mary G. Amato, Henry I. Bussey · Archives of Internal Medicine · 1998 · 594 citations

Drug Interactions Analysis and Management 2009

Melissa Ranieri · Medicine & Science in Sports & Exercise · 2009 · 79 citations

Drug Safety, Drug Interactions, Substance Abuse +14

Generic Warfarin: Implications for Patient Care

Ann K. Wittkowsky · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1997 · 40 citations · Full text

Thrombosis, Medical Treatment, Venous Thrombosis +5

Substitution of Generic Warfarin for Coumadin in an HMO Setting

Paul E. Milligan, Gerald A. Banet, Amy D. Waterman et al. · Annals of Pharmacotherapy · 2002 · 35 citations